Skip to main content
Premium Trial:

Request an Annual Quote

Arrowhead Fails to Meet Nasdaq's Minimum Shareholders' Equity Requirement

Premium

Arrowhead Research, the parent firm of Calando Pharmaceuticals, said this week that it has been notified by the Nasdaq Stock Market that its stockholders' equity does not comply with the exchange's $2.5 million minimum requirement.

Arrowhead said that it has submitted a plan for regaining compliance to the Nasdaq. If the plan is accepted, the company said it may be provided with up to 105 calendar days to demonstrate compliance.

"We are taking action to strengthen our balance sheet to put Arrowhead on a stronger financial footing and expect this will be reflected in our results for the quarter ending June 30, 2009," Arrowhead CEO Christopher Anzalone said in a statement.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.